Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 12/20 | 0.43 |
| ▸ | NPY1R | P25929 | 7/20 | 0.43 |
| ▸ | NPY2R | P49146 | 5/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.41 |
| ▸ | VIPR1 | P32241 | 1/20 | 0.39 |
| ▸ | VIPR2 | P41587 | 1/20 | 0.39 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30111306 | 0.91 | RXFP1 (0.50) | NPY4RNPY1RNPY2RNPY5RRXFP1 | |
| SCHEMBL31670471 | 0.89 | RXFP1 (0.46) | NPY4RNPY1RNPY2RNPY5RRXFP1 | |
| SCHEMBL30111246 | 0.88 | ENPEP (0.47) | — | |
| SCHEMBL31670477 | 0.87 | RXFP1 (0.47) | NPY4RNPY1RNPY2RNPY5RRXFP1 | |
| SCHEMBL30213322 | 0.87 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RRXFP1 | |
| SCHEMBL29678516 | 0.87 | NPY4R (0.43) | NPY4RNPY1RNPY2RNPY5RRXFP1 | |
| SCHEMBL29624007 | 0.86 | VIPR2 (0.52) | RXFP1VIPR1VIPR2PTH1R | |
| SCHEMBL29678410 | 0.86 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RRXFP1 | |
| SCHEMBL31415951 | 0.86 | NPY4R (0.46) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL9346837 | 0.86 | RXFP1 (0.52) | NPY4RNPY1RNPY2RNPY5RRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040091851-A1 | HCV peptide compositions | HOUGHTON MICHAEL (US) | 2004-05-13 | — | — | US | disclosed |
| US-20030232328-A1 | Method of detecting antibodies to HCV | HOUGHTON MICHAEL (US) | 2003-12-18 | — | — | US | disclosed |
| US-20030162167-A1 | METHOD OF DETECTING ANTIBODIES TO HCV | CHIRON CORPORATION | 2003-08-28 | — | — | US | disclosed |
| EP-0318216-B1 | NANBV diagnostics and vaccines | CHIRON CORP (US) | 1993-12-15 | — | — | EP | disclosed |